| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | |
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net loss | ||||||
-32,943 | -39,911 | -32,012 | -23,388 | -12,551 | - | |
Net loss | ||||||
- | - | - | - | - | -5,669 | |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
Depreciation | ||||||
133 | 99 | 94 | 75 | 26 | 27 | |
Forgiveness of accounts payable | ||||||
- | - | - | - | - | 180 | |
Common stock issued for services | ||||||
- | - | - | - | - | 2,063 | |
Stock-based compensation | ||||||
5,561 | 6,625 | 5,646 | 3,269 | 1,600 | - | |
Loss on disposal of equipment | ||||||
- | - | - | -99 | - | - | |
Loss on disposal of equipment | ||||||
- | - | - | - | - | -22 | |
Changes in operating assets and liabilities: | ||||||
Incentive and tax receivables | ||||||
11,169 | -538 | 369 | 3,257 | 356 | - | |
Grant receivables | ||||||
- | - | - | - | - | -34 | |
Prepaid expenses and other assets | ||||||
-1,561 | 1,291 | 324 | 285 | 359 | -437 | |
Deferred grant revenue | ||||||
- | -833 | - | -7 | - | - | |
Right-of-use assets | ||||||
5 | - | - | - | - | - | |
Deferred grant revenue | ||||||
- | - | - | - | -278 | -641 | |
Accounts payable | ||||||
209 | 1,103 | 1,492 | 1,044 | 536 | 140 | |
Accrued expenses | ||||||
1,833 | 1,271 | -369 | 2,011 | 1,597 | 225 | |
Net cash used in operating activities | ||||||
- | - | - | - | - | -3,540 | |
Net cash used in operating activities | ||||||
-34,817 | -32,397 | -25,842 | -20,438 | -9,786 | - | |
Cash flows from investing activities: | ||||||
Purchases of property and equipment | ||||||
129 | 286 | 115 | 109 | 216 | 19 | |
Net cash used in investing activities | ||||||
- | - | - | - | - | -19 | |
Proceeds from issuance of Series B redeemable convertible preferred stock, net | ||||||
- | - | - | - | - | 309 | |
Proceeds from issuance of Series 1 convertible preferred stock, net | ||||||
- | - | - | - | - | 12,925 | |
Net cash used in investing activities | ||||||
-129 | -286 | -115 | -109 | -216 | - | |
Cash flows from financing activities: | ||||||
Proceeds from the issuance of common stock | ||||||
45,187 | 29,937 | 57,293 | 10,000 | 42,122 | - | |
Proceeds from issuance of common stock, net of offering costs | ||||||
- | - | - | - | - | 1 | |
Payment of financing fees and expenses | ||||||
129 | - | 225 | - | - | - | |
Proceeds from the exercise of stock options | ||||||
189 | - | 434 | - | 63 | - | |
Repayment of borrowings | ||||||
- | - | - | - | - | 499 | |
Net cash provided by financing activities | ||||||
- | - | - | - | - | 12,736 | |
Net increase (decrease) in cash and cash equivalents | ||||||
- | - | - | - | - | 9,175 | |
Net cash provided by financing activities | ||||||
45,246 | 29,937 | 57,502 | 10,000 | 42,185 | - | |
Net (decrease) increase in cash and cash equivalents | ||||||
10,299 | -2,746 | 31,544 | -10,547 | - | - | |
Net increase (decrease) in cash and cash equivalents | ||||||
- | - | - | - | 32,182 | - | |
Supplemental disclosures of cash flow information: | ||||||
Deferred financing costs included in accounts payable and accrued expenses | ||||||
63 | 60 | 15 | - | - | - | |
Cash paid for interest | ||||||
- | - | - | - | - | 1 | |
Accrued dividends on redeemable convertible preferred stock | ||||||
- | - | - | - | - | 48 | |
Accretion of redeemable convertible preferred stock | ||||||
- | - | - | - | - | 39 | |
Deferred financing costs included in accounts payable | ||||||
- | - | - | - | - | 1,080 | |
Changes in property and equipment acquired but not paid | ||||||
4 | 20 | - | -19 | -17 | 1 | |
Reclassification of deferred rent liability to right-of-use assets upon adoption of ASC 842 | ||||||
12 | - | - | - | - | - | |
Right-of-use assets and lease liability recorded upon adoption of ASC 842 | ||||||
325 | - | - | - | - | - | |